JP6174040B2 - トラボプロストの調製方法 - Google Patents
トラボプロストの調製方法 Download PDFInfo
- Publication number
- JP6174040B2 JP6174040B2 JP2014548213A JP2014548213A JP6174040B2 JP 6174040 B2 JP6174040 B2 JP 6174040B2 JP 2014548213 A JP2014548213 A JP 2014548213A JP 2014548213 A JP2014548213 A JP 2014548213A JP 6174040 B2 JP6174040 B2 JP 6174040B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- solvent
- process according
- crystallization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MKPLKVHSHYCHOC-AHTXBMBWSA-N travoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(C(F)(F)F)=C1 MKPLKVHSHYCHOC-AHTXBMBWSA-N 0.000 title claims description 42
- 229960002368 travoprost Drugs 0.000 title claims description 42
- 238000002360 preparation method Methods 0.000 title claims description 17
- 238000000034 method Methods 0.000 claims description 46
- 150000001875 compounds Chemical class 0.000 claims description 41
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 33
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 17
- 238000002425 crystallisation Methods 0.000 claims description 17
- 230000008025 crystallization Effects 0.000 claims description 17
- 239000013078 crystal Substances 0.000 claims description 15
- 238000006722 reduction reaction Methods 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- -1 p-phenylbenzoyl protecting group Chemical group 0.000 claims description 11
- 238000005886 esterification reaction Methods 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims description 8
- 230000032050 esterification Effects 0.000 claims description 8
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 claims description 7
- ZDQWVKDDJDIVAL-UHFFFAOYSA-N catecholborane Chemical compound C1=CC=C2O[B]OC2=C1 ZDQWVKDDJDIVAL-UHFFFAOYSA-N 0.000 claims description 7
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 238000007239 Wittig reaction Methods 0.000 claims description 4
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 claims description 4
- 239000012454 non-polar solvent Substances 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 238000011916 stereoselective reduction Methods 0.000 claims description 4
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 3
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 claims description 3
- 125000000686 lactone group Chemical group 0.000 claims description 3
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000006140 methanolysis reaction Methods 0.000 claims description 2
- GNWXVOQHLPBSSR-UHFFFAOYSA-N oxolane;toluene Chemical compound C1CCOC1.CC1=CC=CC=C1 GNWXVOQHLPBSSR-UHFFFAOYSA-N 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 3
- 229930195733 hydrocarbon Natural products 0.000 claims 3
- 150000002430 hydrocarbons Chemical class 0.000 claims 3
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 claims 2
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 238000010898 silica gel chromatography Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- 239000000543 intermediate Substances 0.000 description 29
- 239000000243 solution Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 238000002329 infrared spectrum Methods 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 238000006130 Horner-Wadsworth-Emmons olefination reaction Methods 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- 150000002596 lactones Chemical class 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 229910000085 borane Inorganic materials 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 150000002085 enols Chemical class 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- NNJMFJSKMRYHSR-UHFFFAOYSA-N 4-phenylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=CC=C1 NNJMFJSKMRYHSR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 0 *[C@@](COc1cccc(C(F)(F)F)c1)(*=C[*@@]([C@@](C1)[C@](C2)OC1=O)[C@@]2O*(c(cc1)ccc1-c1ccccc1)=O)O Chemical compound *[C@@](COc1cccc(C(F)(F)F)c1)(*=C[*@@]([C@@](C1)[C@](C2)OC1=O)[C@@]2O*(c(cc1)ccc1-c1ccccc1)=O)O 0.000 description 2
- RTLMATDNIKWIIO-UHFFFAOYSA-N 2-n,2-n,6-n,6-n-tetrakis(2-chloroethyl)-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diamine Chemical compound C=12N=C(N(CCCl)CCCl)N=C(N3CCCCC3)C2=NC(N(CCCl)CCCl)=NC=1N1CCCCC1 RTLMATDNIKWIIO-UHFFFAOYSA-N 0.000 description 2
- VSEVUQXKWHTETG-UHFFFAOYSA-N 2h-cyclopenta[b]furan-2,5-diol Chemical compound OC1=CC2=CC(O)OC2=C1 VSEVUQXKWHTETG-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- RKOTXQYWCBGZLP-UHFFFAOYSA-N N-[(2,4-difluorophenyl)methyl]-2-ethyl-9-hydroxy-3-methoxy-1,8-dioxospiro[3H-pyrido[1,2-a]pyrazine-4,3'-oxolane]-7-carboxamide Chemical compound CCN1C(OC)C2(CCOC2)N2C=C(C(=O)NCC3=C(F)C=C(F)C=C3)C(=O)C(O)=C2C1=O RKOTXQYWCBGZLP-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 229960004132 diethyl ether Drugs 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- WWSWYXNVCBLWNZ-QIZQQNKQSA-N fluprostenol Chemical compound C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(C(F)(F)F)=C1 WWSWYXNVCBLWNZ-QIZQQNKQSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VMKAFJQFKBASMU-KRWDZBQOSA-N (3as)-1-methyl-3,3-diphenyl-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,3,2]oxazaborole Chemical compound C([C@H]12)CCN1B(C)OC2(C=1C=CC=CC=1)C1=CC=CC=C1 VMKAFJQFKBASMU-KRWDZBQOSA-N 0.000 description 1
- VMKAFJQFKBASMU-QGZVFWFLSA-N (r)-2-methyl-cbs-oxazaborolidine Chemical compound C([C@@H]12)CCN1B(C)OC2(C=1C=CC=CC=1)C1=CC=CC=C1 VMKAFJQFKBASMU-QGZVFWFLSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- HJRHGQQOWINKNO-UHFFFAOYSA-N 4-carboxybutylphosphanium;bromide Chemical compound [Br-].OC(=O)CCCC[PH3+] HJRHGQQOWINKNO-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 1
- FLEHAOYBYPJWKG-SHQPEEILSA-N O=C(COc1cccc(C(F)(F)F)c1)/C=C/[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2OC(c(cc1)ccc1-c1ccccc1)=O Chemical compound O=C(COc1cccc(C(F)(F)F)c1)/C=C/[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2OC(c(cc1)ccc1-c1ccccc1)=O FLEHAOYBYPJWKG-SHQPEEILSA-N 0.000 description 1
- XUSJDQTZYULAIE-FDAHFVAYSA-N OCCC(C1)O[C@@H](C[C@H]2OC(c(cc3)ccc3-c3ccccc3)=O)[C@H]1C2/C=C/[C@H](COc1cc(C(F)(F)F)ccc1)O Chemical compound OCCC(C1)O[C@@H](C[C@H]2OC(c(cc3)ccc3-c3ccccc3)=O)[C@H]1C2/C=C/[C@H](COc1cc(C(F)(F)F)ccc1)O XUSJDQTZYULAIE-FDAHFVAYSA-N 0.000 description 1
- VZWHHXZBHHKWAP-QYNIEUIISA-N O[C@@H](COc1cccc(C(F)(F)F)c1)/C=C/[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2OC(c(cc1)ccc1-c1ccccc1)=O Chemical compound O[C@@H](COc1cccc(C(F)(F)F)c1)/C=C/[C@H]([C@@H](C1)[C@H](C2)OC1=O)[C@@H]2OC(c(cc1)ccc1-c1ccccc1)=O VZWHHXZBHHKWAP-QYNIEUIISA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- KHYAFFAGZNCWPT-UHFFFAOYSA-N boron;n,n-diethylaniline Chemical compound [B].CCN(CC)C1=CC=CC=C1 KHYAFFAGZNCWPT-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000012004 corey–bakshi–shibata catalyst Substances 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
[1,1’−ビフェニル]−4−カルボン酸,(3aR,4R,5R,6aS)−ヘキサヒドロ−2−オキソ−4−[(1E)−3−オキソ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]−2H−シクロペンタ[b]フラン−5−イルエステルの調製/式(II)の化合物/
−10℃まで冷却し、この温度を保持しながら、水酸化カリウムを316g加え、続いて、トラボプロストホスホネートのトルエン溶液を1.45kg加える。HWE反応が完了したら、反応混合物を1M塩酸液に注ぎ、混合物を攪拌する。析出した結晶を濾しとり、洗浄する。濾液の相を分離し、有機相を1M炭酸水素ナトリウム溶液で洗浄し、希釈塩酸液で洗浄する。有機相を蒸発させ、シリカゲルカラムにおいてクロマトグラフィによって精製する(溶離液:トルエン−エチルアセテート混合物)。主分画を蒸発させて、エチルアセテート−ヘキサン混合物から結晶化させる。
収率:915g、55%。
融点:112.5から114.5℃
[1,1’−ビフェニル]−4−カルボン酸,(3aR,4R,5R,6aS)−ヘキサヒドロ−4−[(1E,3R)−3−ヒドロキシ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]−2−オキソ−2H−シクロペンタ[b]フラン−5−イルエステルの調製
/式(III)の化合物/
(deとは、ジアステレオマー過剰率を意味する。)
収率:701g、55% de(S):98%
融点:129.5から134.5oC
[1,1’−ビフェニル]−4−カルボン酸,(3aR,4R,5R,6aS)−ヘキサヒドロ−4−[(1E,3R)−3−ヒドロキシ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]−2−ヒドロキシ−シクロペンタ[b]フラン−5−イルエステルの調製
/式(IV)の化合物/
収率:639.5g、91%
4a.
2H−シクロペンタ[b]フラン−2,5−ジオール,ヘキサヒドロ−4−[(1E,3R)−3−ヒドロキシ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]−,(3aR,4R,5R,6aS)−の調製
/式(V)の化合物/
収率:367g、85%
融点:85.4から86.6℃
2H−シクロペンタ[b]フラン−2,5−ジオール,ヘキサヒドロ−4−[(1E,3R)−3−ヒドロキシ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]−,(3aR,4R,5R,6aS)−の再結晶
/式(V)の化合物−トリオール/
析出した結晶を10倍のエチルアセテートに溶かした後、10倍のn−ヘキサンを加え、この溶液を室温にて混合する。得られた結晶懸濁液に、20倍のn−ヘキサンを加え、室温にて混合する。析出した結晶を濾過し、ヘキサン:エチルアセテートの混合物で洗浄し、乾燥させる。上記の方法を任意のタイミングで繰り返すことにより、所望されない異性体の量を任意の量まで減らすことができ、また、所望されない異性体の量を、無視できる限度よりも少ない量(<0,05%)にまで減らすこともできる。
収量:52から85%(再結晶の回数による。)
5−ヘプタン酸,7−[(1R,2R,3R,5S)−3,5−ジヒドロキシ−2−[(1E,3R)−3−ヒドロキシ−4−[3−(トリフルオロメチル)フェノキシ]−1−ブテン−1−イル]シクロペンチル]−,(5Z)−の調製
/式(VI)の化合物/
収量:463g、103%
収量:338.7g、67%
Claims (26)
- 還元は炭化水素系溶媒またはエーテル系溶媒中で行う、請求項1に記載の方法。
- 還元は、トルエン、ヘキサン、ヘプタン、ペンタン、テトラヒドロフラン、メチルテト
ラヒドロフラン、シクロペンチルメチルエーテル、ジメトキシエタン、tert−ブチルメチルエーテル、ジイソプロピルエーテル、ジエチルエーテル、またはこれらの混合物中で行う、請求項2に記載の方法。 - 還元はトルエン−テトラヒドロフラン混合物中で行う、請求項3に記載の方法。
- 還元は−10から−90℃の温度にて行う、請求項1から3のいずれか一項に記載の方法。
- 還元は−10から−20℃の温度にて行う、請求項5に記載の方法。
- 得られた式(III)の化合物を結晶化によって精製する、請求項1から6のいずれか一項に記載の方法。
- 結晶化は、炭化水素系溶媒、塩素化炭化水素系溶媒、エーテル系溶媒、エステル系溶媒、ケトン系溶媒もしくはアルコール系溶媒、またはこれらの混合物中で行う、請求項7に記載の方法。
- 結晶化は、複数の異なる溶媒中またはこれらの混合物中で、繰り返し行う、請求項8に記載の方法。
- 結晶化は、ヘキサン:アセトン混合物中および/またはメタノール中で行う、請求項9に記載の方法。
- 結晶化は、−20から70℃の温度にて行って、物質を還流温度にてアルコールに溶解させ徐々に冷却することにより結晶化するようにし、結晶を濾しとり、洗浄して乾燥させる、請求項7から10のいずれか一項に記載の方法。
- 式(III)の化合物の還元は水素化ジイソブチルアルミニウムを用いて行う、請求項1に記載の方法。
- 式(IV)の化合物のp−フェニルベンゾイル保護基は、塩基性条件下、メタノリシスによって除去する、請求項1に記載の方法。
- 保護基は、炭酸カリウムの存在下で除去する、請求項13に記載の方法。
- 式(V)の中間体を結晶化によって精製する、請求項1に記載の方法。
- 結晶化は、極性溶媒と非極性溶媒との混合物中で行う、請求項15に記載の方法。
- 結晶化は、エチルアセテート−ヘキサン混合物中で行う、請求項16に記載の方法。
- 式(VI)の化合物のエステル化をヨウ化イソプロピルを用いて行う、請求項1に記載の方法。
- エステル化を環状三級アミド系溶媒中で行う、請求項18に記載の方法。
- 環状三級アミド系溶媒としてN−メチルピロリドンまたは1,3−ジメチルイミダゾリジノンを適用する、請求項19に記載の方法。
- エステル化を20から90℃の温度範囲内で行う、請求項18から20のいずれか一項に記載の方法。
- エステル化を40から50℃の温度範囲内で行う、請求項21に記載の方法。
- 式(I)の生成物をクロマトグラフィによって精製する、請求項1に記載の方法。
- 生成物を、重量測定シリカゲルクロマトグラフィによって精製する、請求項23に記載の方法。
- クロマトグラフィによる精製は、炭化水素系溶媒、塩素化炭化水素系溶媒、エーテル系溶媒、エステル系溶媒、アルコール系溶媒、ケトン系溶媒および酸系溶媒またはこれらの混合物を溶離液として用いて行う、請求項24に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1100701 | 2011-12-21 | ||
HU1100701A HU231203B1 (hu) | 2011-12-21 | 2011-12-21 | Új eljárás travoprost előállítására |
PCT/HU2012/000132 WO2013093528A1 (en) | 2011-12-21 | 2012-12-10 | Process for the preparation of travoprost |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015506343A JP2015506343A (ja) | 2015-03-02 |
JP2015506343A5 JP2015506343A5 (ja) | 2015-12-03 |
JP6174040B2 true JP6174040B2 (ja) | 2017-08-02 |
Family
ID=89990547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014548213A Active JP6174040B2 (ja) | 2011-12-21 | 2012-12-10 | トラボプロストの調製方法 |
Country Status (19)
Country | Link |
---|---|
US (2) | US9212125B2 (ja) |
EP (1) | EP2802562B1 (ja) |
JP (1) | JP6174040B2 (ja) |
KR (1) | KR102027889B1 (ja) |
CN (1) | CN103998423B (ja) |
BR (1) | BR112014014060A2 (ja) |
CA (1) | CA2859923C (ja) |
ES (1) | ES2721662T3 (ja) |
HK (1) | HK1198584A1 (ja) |
HU (1) | HU231203B1 (ja) |
IL (1) | IL232625B (ja) |
IN (1) | IN2014CN03482A (ja) |
MX (1) | MX2014007684A (ja) |
PL (1) | PL2802562T3 (ja) |
RU (1) | RU2631316C2 (ja) |
TR (1) | TR201905687T4 (ja) |
TW (1) | TWI640500B (ja) |
WO (1) | WO2013093528A1 (ja) |
ZA (1) | ZA201404440B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9238621B2 (en) * | 2011-06-02 | 2016-01-19 | Chinoin Zrt | Processes for the preparation of prostaglandin amides |
US9115109B2 (en) * | 2013-08-15 | 2015-08-25 | Chirogate International Inc. | Processes and intermediates for the preparations of isomer free prostaglandins |
HU231214B1 (hu) * | 2014-03-13 | 2021-11-29 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Új eljárás nagytisztaságú prosztaglandinok előállítására |
US11458041B2 (en) | 2015-10-08 | 2022-10-04 | Ocular Therapeutix, Inc. | Punctal plug and bioadhesives |
CA3132572A1 (en) * | 2019-03-27 | 2020-10-01 | Kyowa Pharma Chemical Co., Ltd. | Method for producing pkrostaglandin |
JP7451732B2 (ja) | 2020-02-06 | 2024-03-18 | オキュラ セラピューティクス,インコーポレイテッド | 眼疾患を治療するための組成物及び方法 |
US20240010615A1 (en) * | 2020-12-23 | 2024-01-11 | Kyowa Pharma Chemical Co., Ltd. | Method for separating geometrical isomer |
CN114671906B (zh) * | 2020-12-24 | 2024-03-15 | 武汉武药制药有限公司 | 制备曲伏前列素中间体的方法 |
CN115806517A (zh) * | 2022-12-21 | 2023-03-17 | 上海彩迩文生化科技有限公司 | 一种高纯度地诺前列腺素的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2328131C3 (de) * | 1973-05-30 | 1986-11-13 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neues Verfahren zur Herstellung von Prostaglandin-F↓2↓↓α↓ und seinen Analogen |
HU184948B (en) * | 1981-04-14 | 1984-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives |
HU190007B (en) | 1982-05-06 | 1986-08-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for producing new aromatic prostacylin analogues |
CS239696B1 (cs) * | 1984-05-03 | 1986-01-16 | Jiri Hajek | Způsob dělení 15S-a 15R-isomerů 4-/4-/substituovaných X-fenoxy/-3-hydroxy-1butenyí/hexahydro-5-hydroxy- -2H-cyklopenta[b]furan-2-onů |
HU212570B (en) * | 1991-06-24 | 1996-08-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 13,14-dihydro-15(r)-17-phenyl-18,19,20-trinor-pgf2alfa-isopropylester |
US5510383A (en) | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
GB0112699D0 (en) * | 2001-05-24 | 2001-07-18 | Resolution Chemicals Ltd | Process for the preparation of prostglandins and analogues thereof |
GB0329379D0 (en) * | 2003-12-19 | 2004-01-21 | Johnson Matthey Plc | Prostaglandin synthesis |
NZ548271A (en) * | 2004-01-05 | 2010-01-29 | Nicox Sa | Prostaglandin nitrooxyderivatives |
EP2143712A1 (en) | 2008-07-10 | 2010-01-13 | Sandoz AG | Improved Process for the Production of Prostaglandins and Prostaglandin Analogs |
IT1393112B1 (it) * | 2009-02-27 | 2012-04-11 | Sifavitor S R L | Procedimento per la preparazione di derivati di prostaglandine |
NZ599316A (en) * | 2009-10-16 | 2013-02-22 | Cayman Chemical Co Inc | Process for the preparation of f-series prostaglandins |
CA2777352A1 (en) | 2009-11-05 | 2011-05-12 | Biocon Limited | A novel process for the preparation of prostaglandins and intermediates thereof |
EP2495235B1 (en) | 2011-03-04 | 2015-08-05 | Newchem S.p.A. | Process for the synthesis of prostaglandins and intermediates thereof |
US9238621B2 (en) | 2011-06-02 | 2016-01-19 | Chinoin Zrt | Processes for the preparation of prostaglandin amides |
-
2011
- 2011-12-21 HU HU1100701A patent/HU231203B1/hu unknown
-
2012
- 2012-12-10 IN IN3482CHN2014 patent/IN2014CN03482A/en unknown
- 2012-12-10 CN CN201280063528.2A patent/CN103998423B/zh active Active
- 2012-12-10 KR KR1020147020311A patent/KR102027889B1/ko active IP Right Grant
- 2012-12-10 BR BR112014014060A patent/BR112014014060A2/pt not_active Application Discontinuation
- 2012-12-10 JP JP2014548213A patent/JP6174040B2/ja active Active
- 2012-12-10 WO PCT/HU2012/000132 patent/WO2013093528A1/en active Application Filing
- 2012-12-10 US US14/367,317 patent/US9212125B2/en active Active
- 2012-12-10 PL PL12816098T patent/PL2802562T3/pl unknown
- 2012-12-10 TR TR2019/05687T patent/TR201905687T4/tr unknown
- 2012-12-10 CA CA2859923A patent/CA2859923C/en active Active
- 2012-12-10 RU RU2014129492A patent/RU2631316C2/ru active
- 2012-12-10 MX MX2014007684A patent/MX2014007684A/es unknown
- 2012-12-10 EP EP12816098.3A patent/EP2802562B1/en active Active
- 2012-12-10 ES ES12816098T patent/ES2721662T3/es active Active
- 2012-12-20 TW TW101148584A patent/TWI640500B/zh active
-
2014
- 2014-05-14 IL IL232625A patent/IL232625B/en active IP Right Grant
- 2014-06-17 ZA ZA2014/04440A patent/ZA201404440B/en unknown
- 2014-12-01 HK HK14112063.1A patent/HK1198584A1/xx unknown
-
2015
- 2015-10-30 US US14/928,629 patent/US20160137621A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2802562B1 (en) | 2019-01-23 |
US20140343299A1 (en) | 2014-11-20 |
HU231203B1 (hu) | 2021-10-28 |
TWI640500B (zh) | 2018-11-11 |
TW201336816A (zh) | 2013-09-16 |
ES2721662T3 (es) | 2019-08-02 |
CN103998423A (zh) | 2014-08-20 |
MX2014007684A (es) | 2014-07-28 |
HUP1100701A2 (en) | 2013-07-29 |
CN103998423B (zh) | 2018-04-27 |
PL2802562T3 (pl) | 2019-08-30 |
CA2859923C (en) | 2020-11-24 |
US9212125B2 (en) | 2015-12-15 |
BR112014014060A2 (pt) | 2017-06-13 |
IL232625B (en) | 2019-03-31 |
EP2802562A1 (en) | 2014-11-19 |
KR20140107541A (ko) | 2014-09-04 |
WO2013093528A1 (en) | 2013-06-27 |
RU2631316C2 (ru) | 2017-09-21 |
CA2859923A1 (en) | 2013-06-27 |
IN2014CN03482A (ja) | 2015-07-03 |
US20160137621A1 (en) | 2016-05-19 |
JP2015506343A (ja) | 2015-03-02 |
RU2014129492A (ru) | 2016-02-10 |
ZA201404440B (en) | 2015-12-23 |
TR201905687T4 (tr) | 2019-05-21 |
HK1198584A1 (en) | 2015-04-30 |
IL232625A0 (en) | 2014-06-30 |
KR102027889B1 (ko) | 2019-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6174040B2 (ja) | トラボプロストの調製方法 | |
JP3989377B2 (ja) | プロスタグランジン誘導体の製造方法及びその立体特異的出発物質 | |
JP5485980B2 (ja) | プロスタグランジン類似物の製造方法及びその中間体 | |
KR101045935B1 (ko) | 프로스타글란딘 유도체의 제조방법 | |
JP2005503354A5 (ja) | ||
JP2015506343A5 (ja) | ||
JP2010100629A (ja) | プロスタグランジン誘導体の製造方法及びその出発物質 | |
EP2143712A1 (en) | Improved Process for the Production of Prostaglandins and Prostaglandin Analogs | |
JP2008037782A (ja) | プロスタグランジン誘導体の製造方法 | |
JP5554888B2 (ja) | プロスタグランジンを調製するためのプロセス及び中間体 | |
US7642370B2 (en) | Method for preparing prostaglandin derivative | |
CN109096324B (zh) | 一种二烷基酰基氯化锗合成方法与应用 | |
KR20190016820A (ko) | 라타노프로스틴 부노드의 제조 방법 및 그를 위한 중간체 | |
JP4510300B2 (ja) | プロスタグランジンの合成のための新規中間体 | |
CN117843599A (zh) | 一种含有1-烷基-1-烯基乙醇结构的前列腺素中间体的制备方法 | |
EP1398312A1 (en) | Beta-substituted-gamma-butyrolactones and a process for preparation thereof | |
CN104520282A (zh) | 制备苯并呋喃衍生物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151009 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151009 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20160205 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160208 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160623 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160705 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161004 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20170207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170526 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20170609 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170627 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170705 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6174040 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |